Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial 9q- deletions in hematologic malignancies.

C Mecucci, K Vermaelen, G Kulling

    Cancer Genetics and Cytogenetics
    |August 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A novel germline mutation in CDK4 codon 24 associated to familial melanoma.

    Clinical genetics·2017
    Same author

    Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin.

    Leukemia·2017
    Same author

    NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group.

    Leukemia·2016
    Same author

    Translocation (14;19)(q32;q13.1) in a Young Patient who Developed a Large Cell Lymphoma after an Initial Diagnosis of CLL.

    Leukemia & lymphoma·2016
    Same author

    Two Translocations: a Follicular Variant 2; 18 and a Burkitt 8;14 in a Small Non Cleaved Non Hodgkin's Lymphoma.

    Leukemia & lymphoma·2016
    Same author

    The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes.

    Leukemia & lymphoma·2016
    Same journal

    Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

    Cancer genetics and cytogenetics·2010
    Same journal

    A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

    Cancer genetics and cytogenetics·2010
    Same journal

    A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

    Cancer genetics and cytogenetics·2010
    Same journal

    Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

    Cancer genetics and cytogenetics·2010
    Same journal

    Chromosomal imbalances in urinary bladder paraganglioma.

    Cancer genetics and cytogenetics·2010
    Same journal

    A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

    Cancer genetics and cytogenetics·2010
    See all related articles

    Interstitial deletions of chromosome 9q are primarily linked to myeloproliferative disorders. This chromosomal anomaly often occurs alongside other genetic changes, notably t(8;21), and is not associated with the abl oncogene region.

    Area of Science:

    • Cytogenetics
    • Hematology
    • Oncology

    Background:

    • Interstitial deletions of the long arm of chromosome 9 (9q-) are rare chromosomal abnormalities.
    • Understanding their role in hematological malignancies is crucial for diagnosis and prognosis.

    Observation:

    • A study of 16 patients with 9q- and review of 10 literature cases were conducted.
    • The 9q- deletion was analyzed for its frequency, association with other genetic anomalies, and breakpoint locations.

    Findings:

    • The 9q- deletion is almost exclusively observed in myeloproliferative disorders.
    • It rarely presents as the sole genetic anomaly, frequently co-occurring with a translocation t(8;21) in over a third of cases.
    • Breakpoints are variable and do not involve the abl oncogene region.

    Related Experiment Videos

    Implications:

    • The 9q- deletion serves as a significant indicator in the context of myeloproliferative neoplasms.
    • Its frequent association with t(8;21) suggests a potential role in disease progression or specific subtypes.
    • The absence of abl oncogene involvement clarifies the molecular landscape of these deletions.